Expert Opinion on Pharmacotherapy

Combination pharmaceutical therapies for obesity
pp. 921-925(5)
Authors: Gadde, Kishore M; Allison, David B

Baseline severity of depression predicts antidepressant drug response relative to escitalopram
pp. 927-936(10)
Authors: Kilts, Clinton D; Wade, Alan G; Andersen, Henning F; Schlaepfer, Thomas E

Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients
pp. 937-945(9)
Authors: Stamouli, SS; Yfantis, A; Lamboussis, E; Liakouras, A; Lagari, V; Tzanakaki, M; Giailoglou, D; Legault, M; Parashos, IA

Treatment strategies for cancer patients with breakthrough pain
pp. 947-953(7)
Authors: Casuccio, Alessandra; Mercadante, Sebastiano; Fulfaro, Fabio

Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control
pp. 955-966(12)
Authors: Papademetriou, Vasilios; Doumas, Michael

Therapeutic options for metastatic breast cancer
pp. 967-981(15)
Authors: Morris, Patrick G; McArthur, Heather L; Hudis, Clifford A

Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
pp. 983-995(13)
Authors: Prichard, Mark; Harris, Thomas; Williams, Michael E; Densmore, John J

Prevention of glucocorticoid-induced osteoporosis
pp. 997-1005(9)
Authors: van Brussel, MS; Bultink, IEM; Lems, WF

The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth
pp. 1007-1016(10)
Authors: Jayasooriya, GS; Lamont, RF

Treatment strategies for alopecia
pp. 1017-1026(10)
Authors: Tosti, Antonella; Duque-Estrada, Bruna

Apomorphine in the treatment of Parkinson disease and other movement disorders
pp. 1027-1038(12)
Author: Gunzler, Steven A

Methylnaltrexone: the answer to opioid-induced constipation?
pp. 1039-1045(7)
Authors: Cannom, Rebecca R; Mason, Rodney J

Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective
pp. 1047-1058(12)
Authors: Brugaletta, Salvatore; Burzotta, Francesco; Sabaté, Manel

Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs
pp. 1059-1067(9)
Authors: Silasi, Dan-Arin; Alvero, Ayesha B; Rutherford, Thomas J; Brown, David; Mor, Gil

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity
pp. 1069-1081(13)
Authors: Plodkowski, Raymond A; Nguyen, Quang; Sundaram, Umasankari; Nguyen, Loida; Chau, Diane L; St Jeor, Sachiko

Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty
pp. 1083-1088(6)
Author: Borris, Lars C

Highlights of the Pananemia National meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia
pp. 1089-1093(5)
Authors: Addeo, Raffaele; Caraglia, Michele; Del Prete, Salvatore